Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESGO 2021 | Highlights for pathology at ESGO

Xavier Matias-Guiu • 25 Oct 2021
ESGO 2021
Endometrial Cancer Gynecological Cancer Ovarian Cancer

Xavier Matias-Guiu, PhD, Biomedical Research Institute of Lleida, Lleida, Spain, discusses the highlights for pathology at ESGO 2021, including advances in classification and biomarkers. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

More from Xavier Matias-Guiu

Importance of pathology in gynecological cancer
1:40
Importance of pathology in gynecological cancer
Xavier Matias-Guiu • 25 Oct 2021
Pathologic risk stratification of gynecological cancer
0:54
Pathologic risk stratification of gynecological cancer
Xavier Matias-Guiu • 25 Oct 2021

Related Videos

The future of antibody-drug conjugates in endometrial cancer
1:10
The future of antibody-drug conjugates in endometrial cancer
Linda Mileshkin • 30 May 2026
B7-H4-directed ADC in endometrial versus ovarian cancer
0:43
B7-H4-directed ADC in endometrial versus ovarian cancer
Linda Mileshkin • 30 May 2026
Barriers to cervical cancer screening among rural women in India
0:54
Barriers to cervical cancer screening among rural women in India
Shailendra Dandge • 31 May 2026
A community-based model for cervical cancer screening uptake in rural India
8:39
A community-based model for cervical cancer screening uptake in rural India
Shailendra Dandge • 31 May 2026
The content of VJOncology is intended for healthcare professionals